Advertisement

Studies in man using semi-tracer doses of deuterated phenylalanine and tyrosine: implications for the investigation of phenylketonuria using the deuterated phenylalanine load test

  • J. A. Hoskins
  • R. J. Pollitt

Abstract

In classical phenylketonuria there is a virtual absence of phenylalanine hydroxylase activity in the liver, the organ usually responsible for catabolism of excessive dietary phenylalanine. The accumulation of phenylalanine, and possibly some of its metabolites, results in severe mental retardation. Consequently, great effort is put into detecting the disorder in the first few weeks of life so that it can be treated by restriction of phenylalanine intake. Unfortunately, it is sometimes difficult to classify cases detected by screening in the newborn period and there appears to be an almost continuous gradation from the classical phenylketonuric to the normal individual. Attempts to differentiate sub-groups of the disease by estimating phenylalanine hydroxylase in liver biopsy specimens have been made at various centres but the situation still remains confused. The normal phenylalanine loading tests using oral doses of 100–200 mg/kg body weight are difficult to interpret and, although the results of intravenous loading tests are more amenable to rigorous mathematical treatment (Woolf, Cranston and Goodwin, 1967), this has not proved to be an acceptable procedure for routine use with the newborn child.

Keywords

Labelling Pattern Mandelic Acid Phenylalanine Hydroxylase Urinary Acid Plasma Phenylalanine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blau, K., Goodwin, B., Woods, H. F. and Youdim, M. B. H. (1976). Brit. J. Pharmacol., 58, 474 PGoogle Scholar
  2. Boulton, A. A. and Dyck, L. E. (1974). Life Sci., 14, 2497CrossRefGoogle Scholar
  3. Bu’Lock, J. D. and Ryles, A. P. (1970). Chem. Commun., 1404Google Scholar
  4. Chalmers, R. A. and Watts, R. W. E. (1974). Clin. Chim. Acta, 55, 281CrossRefGoogle Scholar
  5. Coulson, W. F., Henson, G. and Jepson, J. B. (1968). Biochem. Biophys. Acta, 156, 135CrossRefGoogle Scholar
  6. Curtius, H.-Ch., Völlmin, J. A. and Baerlocher, K. (1972a). Clin. Chim. Acta, 37, 277CrossRefGoogle Scholar
  7. Curtius, H.-Ch., Völlmin, J. A. and Baerlocher, K. (1972b). Organic Acidurias, S.S.LE.M. Symposium 9 (ed. J. Stern and C. Toothill), Churchill Livingstone, Edinburgh, p. 146Google Scholar
  8. Fellman, J. H., Buist, N. R. M., Kennaway, N. G. and Swanson, R. E. (1972). Clin. Chim. Acta, 39, 243CrossRefGoogle Scholar
  9. Jones, R. A. D., Lee, C. R. and Pollitt, R. J. (1977). This symposium.Google Scholar
  10. Kirby, G. W. and Ogunkoya, J. (1965). J. Chem. Soc., 6914Google Scholar
  11. Tong, J. H., D’Iorio, A. and Benoiton, N. L. (1971). Biochem. Biophys. Res. Commun., 44, 229CrossRefGoogle Scholar
  12. Woolf, L. I., Cranston, W. I. and Goodwin, B. L. (1967). Nature, 213, 882CrossRefGoogle Scholar

Copyright information

© The Contributors 1978

Authors and Affiliations

  • J. A. Hoskins
    • 1
  • R. J. Pollitt
    • 1
  1. 1.MRC Unit for Metabolic Studies in Psychiatry, University Department of PsychiatryMiddlewood HospitalSheffieldUK

Personalised recommendations